Listen to the new episode of the Clinical Trial Files podcast, where Karin Avila, Taymeyah Al-Toubah and Thomas Wood of Fast Data Science chat about AI and NLP in pharma, the Clinical Trial Risk Tool, what impact AI can make in clinical trials. This episode commemorates Alan Turing’s 113rd birthday on 23 June 2025.
The group chatted about how a team of data scientists together with clinical professionals can be much greater than the sum of its parts, and what traditional machine learning, statistics, and generative AI can achieve in the clinical research field.
Thomas Wood also discussed the thinking behind Fast Data Science’s flagship product, the Clinical Trial Risk Tool, and why and how this tool came to exist and how it’s helping clinical researchers validate protocols. Karin and Taymeyah told us about the exciting developments in AI that they are seeing in clinical research.
The Clinical Trial Files podcast is organised by Karin Avila, Taymeyah Al-Toubah, and Roberto Torres. You can listen below on Spotify:
You can find the Clinical Trial Files podcast episode on
Dive into the world of Natural Language Processing! Explore cutting-edge NLP roles that match your skills and passions.
Explore NLP Jobs
We are excited to introduce the new Harmony Meta platform, which we have developed over the past year. Harmony Meta connects many of the existing study catalogues and registers.
Guest post by Jay Dugad Artificial intelligence has become one of the most talked-about forces shaping modern healthcare. Machines detecting disease, systems predicting patient deterioration, and algorithms recommending personalised treatments all once sounded like science fiction but now sit inside hospitals, research labs, and GP practices across the world.
If you are developing an application that needs to interpret free-text medical notes, you might be interested in getting the best possible performance by using OpenAI, Gemini, Claude, or another large language model. But to do that, you would need to send sensitive data, such as personal healthcare data, into the third party LLM. Is this allowed?
What we can do for you
